Caris Halbert, L.P. (CIK 2072109) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-06-23). Recent activity: Buy CAI (360,750 shares), Buy CAI (413,839 shares), Buy CAI (104.8M shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-06-23 | Caris Life Sciences, Inc. (CAI) | Director | Buy | 360,750 | $0 |
| 2025-06-23 | Caris Life Sciences, Inc. (CAI) | Director | Buy | 413,839 | $0 |
| 2025-06-23 | Caris Life Sciences, Inc. (CAI) | Director | Buy | 104.8M | $0 |
Source: SEC Form 4 filings · as of 2025-06-23